Wilms' tumor gene peptide vaccine (Osaka University)

WT1多肽疫苗（大阪大学）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameWilms' tumor gene peptide vaccine (Osaka University)

Drug Alias NameWilms' tumor gene peptide-based vaccineWT1 peptide vaccineWT1 gene peptide-based vaccine

ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Synthetic peptide vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsLung Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesOsaka University

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsLung Neoplasms

Inactive IndicationsN/A

ATC CodeN/A